The highest enzyme inhibitory activity was observed in β-secretase (BACE-1) (54.61% inhibition at the extraction concentration of 8 mg/mL), the β-amyloid formation enzyme, which is a drug target for Alzheimer’s disease (AD) treatment. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.